脑龄范式纵向评估多发性硬化
本研究基于3565次MRI扫描(1204例MS/CIS患者与150例健康对照),采用T1加权MRI建立脑龄预测模型。结果显示MS患者脑龄差(brain-PAD)显著高于健康对照(+10.3年 vs +4.3年,p<0.001),基线brain-PAD可预测残疾进展时间,且brain-PAD年增长与EDSS年增长相关。
要点
- MS患者brain-PAD较健康对照高约6年,提示脑龄加速。
- 继发进展型MS患者brain-PAD最高(+13.3年)。
- 基线brain-PAD越高,残疾进展越快(HR 1.02)。
核心结论
- 脑龄范式对MS相关脑萎缩和临床进展敏感,高brain-PAD与更快的残疾进展相关。
研究设计与样本
- 纵向多中心研究,纳入1204例MS和CIS患者及150例健康对照,共3565次MRI扫描,患者平均随访3.41年,健康对照1.97年,使用T1加权MRI测量脑龄预测年龄。
主要发现
- MS患者平均brain-PAD为+10.3年(95%CI 8.5-12.1),健康对照为+4.3年(95%CI 2.1-6.4),p<0.001。
- 继发进展型MS的brain-PAD最高,为+13.3年(95%CI 11.3-15.3)。
- 基线brain-PAD预测残疾进展时间(HR 1.02,95%CI 1.01-1.03,p<0.001),但归一化脑体积是更强的预测因子。
- brain-PAD年增长与EDSS年增长相关(r=0.26,p<0.001)。
临床怎么用
- 脑龄可能作为早期MS的预后生物标志物,用于追踪疾病进展或临床试验分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: During the natural course of multiple sclerosis (MS), the brain is exposed to aging as well as disease effects. Brain aging can be modeled statistically; the so-called "brain-age" paradigm. Here, we evaluated whether brain-predicted age difference (brain-PAD) was sensitive to the presence of MS, clinical progression, and future outcomes. METHODS: In a longitudinal, multicenter sample of 3,565 magnetic resonance imaging (MRI) scans, in 1,204 patients with MS and clinically isolated syndrome (CIS) and 150 healthy controls (mean follow-up time: patients 3.41 years, healthy controls 1.97 years), we measured "brain-predicted age" using T1-weighted MRI. We compared brain-PAD among patients with MS and patients with CIS and healthy controls, and between disease subtypes. Relationships between brain-PAD and Expanded Disability Status Scale (EDSS) were explored. RESULTS: Patients with MS had markedly higher brain-PAD than healthy controls (mean brain-PAD +10.3 years; 95% confidence interval [CI] = 8.5-12.1] versus 4.3 years; 95% CI = 2.1 to 6.4; p < 0.001). The highest brain-PADs were in secondary-progressive MS (+13.3 years; 95% CI = 11.3-15.3). Brain-PAD at study entry predicted time-to-disability progression (hazard ratio 1.02; 95% CI = 1.01-1.03; p < 0.001); although normalized brain volume was a stronger predictor. Greater annualized brain-PAD increases were associated with greater annualized EDSS score (r = 0.26; p < 0.001). INTERPRETATION: The brain-age paradigm is sensitive to MS-related atrophy and clinical progression. A higher brain-PAD at baseline was associated with more rapid disability progression and the rate of change in brain-PAD related to worsening disability. Potentially, "brain-age" could be used as a prognostic biomarker in early-stage MS, to track disease progression or stratify patients for clinical trial enrollment. ANN NEUROL 2020 ANN NEUROL 2020;88:93-105.
引用
- Cole JH, Raffel J, Friede T, et al. Longitudinal Assessment of Multiple Sclerosis with the Brain-Age Paradigm. Ann Neurol. 2020. PMID: 32285956. doi:10.1002/ana.25746
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。